References
35
Referenced
80
10.1038/nrd707
/ Nat. Rev. Drug Discov. / Moving smaller in drug discovery and delivery by LaVan (2002)10.1038/nrd1088
/ Nat. Rev. Drug Discov. / The dawning era of polymer therapeutics by Duncan (2003)10.1016/S0169-409X(02)00226-0
/ Adv. Drug Deliv. Rev. / PEGylated nanoparticles for biological and pharmaceutical applications by Otsuka (2003)10.1016/j.ymthe.2003.10.002
/ Molec. Ther. / Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy by Schek (2004)10.1073/pnas.152463399
/ Proc. Natl. Acad. Sci. U. S. A. / Nanocrystal targeting in vivo by Akerman (2002)10.1126/science.296.5569.838
/ Science / Drug delivery. Breaching the membrane by Alper (2002)10.1038/nrd837
/ Nat. Rev. Drug Discov. / Nucleic-acid therapeutics: basic principles and recent applications by Opalinska (2002)10.1007/BF02976827
/ Arch. Pharm. Res. / Antisense DNAs as targeted genetic medicine to treat cancer by Cho-Chung (2003)10.1006/mthe.2002.0805
/ Molec. Ther. / Repair of a splicing defect in erythroid cells from patients with beta-thalassemia/HbE disorder by Suwanmanee (2002)10.1016/S0140-6736(03)14637-5
/ Lancet / Small RNA: can RNA interference be exploited for therapy? by Wall (2003)10.1038/nm828
/ Nat. Med. / RNA interference targeting Fas protects mice from fulminant hepatitis by Song (2003)10.1016/S0169-409X(01)00214-9
/ Adv. Drug Deliv. Rev. / Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development by Kunisawa (2001)10.1073/pnas.0930644100
/ Proc. Natl. Acad. Sci. U. S. A. / A macromolecular delivery vehicle for protein-based vaccines: acid-degradable protein-loaded microgels by Murthy (2003)10.1038/nbt1201-1173
/ Nat. Biotechnol. / A peptide carrier for the delivery of biologically active proteins into mammalian cells by Morris (2001)10.1038/sj.gt.3301966
/ Gene Ther. / Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes by Mathew (2003)10.1006/bbrc.1996.0070
/ Biochem. Biophys. Res. Commun. / Efficient gene transfer into mammalian cells using fusogenic liposome by Mizuguchi (1996){'issue': '24', 'key': '10.1016/j.jconrel.2005.03.020_bib17', 'first-page': '5725', 'article-title': 'Tumor necrosis factor alpha-mediated tumor regression by the in vivo transfer of genes into the artery that leads to tumors', 'volume': '58', 'author': 'Mizuguchi', 'year': '1998', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Tumor necrosis factor alpha-mediated tumor regression by the in vivo transfer of genes into the artery that leads to tumors by Mizuguchi (1998)10.1038/bjc.1996.83
/ Br. J. Cancer / Application of fusogenic liposomes containing fragment A of diphtheria toxin to cancer therapy by Mizuguchi (1996)10.1002/1521-4141(200006)30:6<1740::AID-IMMU1740>3.0.CO;2-U
/ Eur. J. Immunol. / Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway by Nakanishi (2000)10.1006/bbrc.1999.1044
/ Biochem. Biophys. Res. Commun. / A novel vaccine delivery system using immunopotentiating fusogenic liposomes by Hayashi (1999)10.4049/jimmunol.167.3.1406
/ J. Immunol. / Sendai virus fusion protein mediates simultaneous induction of MHC class I/II-dependent mucosal and systemic immune responses via the nasopharyngeal-associated lymphoreticular tissue immune system by Kunisawa (2001)10.4049/jimmunol.170.1.495
/ J. Immunol. / HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses by Sakaue (2003)10.1002/(SICI)1099-081X(199610)17:7<589::AID-BDD976>3.0.CO;2-D
/ Biopharm. Drug Dispos. / Biopharmaceutical evaluation of the liposomes prepared by rehydration of freeze-dried empty liposomes (FDELs) with an aqueous solution of a drug by Yachi (1996)10.1016/S0378-5173(02)00113-8
/ Int. J. Pharm. / Optimized chemical structure of nanoparticles as carriers for oral delivery of salmon calcitonin by Sakuma (2002)10.1091/mbc.01-06-0308
/ Mol. Biol. Cell / Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm by Pante (2002)10.4049/jimmunol.158.6.2723
/ J. Immunol. / Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules by Shen (1997)10.1016/S0168-3659(97)00220-4
/ J. Control. Release / Gene transfer vectors based on Sendai virus by Nakanishi (1998)10.1016/j.ymthe.2003.09.011
/ Molec. Ther. / Deoxyribonuclease II is a lysosomal barrier to transfection by Howell (2003)10.1002/jps.10286
/ J. Pharm. Sci. / Barriers to nonviral gene delivery by Wiethoff (2003)10.1163/156856297X00173
/ J. Biomater. Sci., Polym. Ed. / Injectable microcapsules prepared with biodegradable poly(alpha-hydroxy) acids for prolonged release of drugs by Ogawa (1997)10.1021/js950204r
/ J. Pharm. Sci. / Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(beta-benzyl l-aspartate) block copolymer micelles by La (1996)10.1016/S0264-410X(00)00094-3
/ Vaccine / Characterization of mucoadhesive microspheres for the induction of mucosal and systemic immune responses by Kunisawa (2000)10.1096/fj.02-0088com
/ FASEB J. / Rapid endo-lysosomal escape of poly(dl-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery by Panyam (2002)10.1073/pnas.151247498
/ Proc. Natl. Acad. Sci. U. S. A. / TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors by Torchilin (2001)10.1073/pnas.0435906100
/ Proc. Natl. Acad. Sci. U. S. A. / Cell transfection in vitro and in vivo with nontoxic TAT peptide–liposome–DNA complexes by Torchilin (2003)
Dates
Type | When |
---|---|
Created | 20 years, 2 months ago (June 6, 2005, 4:56 p.m.) |
Deposited | 2 years, 3 months ago (May 3, 2023, 5:40 a.m.) |
Indexed | 1 month ago (July 25, 2025, 6:01 a.m.) |
Issued | 20 years, 1 month ago (July 1, 2005) |
Published | 20 years, 1 month ago (July 1, 2005) |
Published Print | 20 years, 1 month ago (July 1, 2005) |
Funders
3
Core Research for Evolutional Science and Technology
10.13039/501100003382
Region: Asia
gov (Local government)
Labels
3
- Core Research for Evolutionary Science and Technology
- 進化科学技術のコア研究
- CREST
Japan Science and Technology Corporation
10.13039/501100001695
Region: Asia
pri (Other non-profit organizations)
Labels
1
- JST
Ministry of Education, Culture, Sports, Science and Technology
10.13039/501100001700
Region: Asia
gov (National government)
Labels
3
- Monbu-kagaku-shō
- 文部科学省
- MEXT
@article{Kunisawa_2005, title={Fusogenic liposome delivers encapsulated nanoparticles for cytosolic controlled gene release}, volume={105}, ISSN={0168-3659}, url={http://dx.doi.org/10.1016/j.jconrel.2005.03.020}, DOI={10.1016/j.jconrel.2005.03.020}, number={3}, journal={Journal of Controlled Release}, publisher={Elsevier BV}, author={Kunisawa, Jun and Masuda, Takashi and Katayama, Kazufumi and Yoshikawa, Tomoaki and Tsutsumi, Yasuo and Akashi, Mitsuru and Mayumi, Tadanori and Nakagawa, Shinsaku}, year={2005}, month=jul, pages={344–353} }